Pirfenidone in Adult Hospitalized Patients With COVID-19

Summary

This center intends to conduct a multicenter, randomized, placebo-controlled study to evaluate the effectiveness and safety of Nintedanib ethanesulfonate soft capsule in the treatment of pulmonary fibrosis in patients with moderate to severe COVID-19.

Timeline

Start

2022-12-01

Primary completion

2023-03-04

Completion

2023-03-30

Drugs

Indications